BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-33@pharmaconomics
DTSTAMP:20260707T003350Z
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261007
SUMMARY:BMY Phase 3 — BMS-986278
DESCRIPTION:Phase 3 trial results for BMS-986278 in Idiopathic Pulmonary Fibrosis are due Oct 6\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT06003426\n\nTrack it: https://pharmaconomics.com/e/33
URL:https://pharmaconomics.com/e/33
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:BMY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR